Utilization rates of hip arthroplasty in OECD countries revised
Osteoarthritis and Cartilage · 2025-12 · 33 (12) · 1475-1484
DOI: 10.1016/j.joca.2025.09.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2025-12. Verfasst von Jonas Backes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Health Economics, Policy and Management, School of Medicine, University of St. Gallen, Switzerland. Electronic address: jonas.backes@unisg.c…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: In 2014, we reported rising hip arthroplasty utilization across Organization for Economic Co-operation and Development (OECD) countries, particularly among younger patients. Since then, healthcare systems have evolved, demographic shifts are continued, and procedures were impacted by the COVID-19 pandemic. This study aims to reassess these trends through 2022. METHODS: We analyzed hip arthroplasty data from the OECD Health Statistics, U.S. Nationwide Inpatient Sample, and World Bank for 27 countries (2005-2022). We compared relative (compound annual growth rates (CAGR)) and absolute (i.e., mean annual differences (MAD)) procedure numbers, stratified by age (≤64 vs. ≥65), and examined associations with GDP, health expenditure, and life expectancy. Sensitivity analyses were performed to account for uncertainty in U.S. RESULTS: Between 2011 and 2022, hip arthroplasty utilization grew more slowly than 2005-2011 (CAGR: 1.00% vs. 2.03%; MAD: 1.78 vs. 2.03). Growth from 2011 to 2022 was concentrated among patients aged ≤64 (CAGR 3.08%; MAD: 3.11), while utilization declined among those ≥65 (CAGR: -2.27%; MAD: -12.46). Country-level variation narrowed, with the highest-to-lowest ratio falling from 6.65 (2005) to 2.96 (2022). Despite a sharp drop in 2020 due to COVID-19, most countries recovered by 2022. Sensitivity analyses confirmed the robustness of observed OECD trends. BRIC nations showed faster growth, but data limitations hindered comparisons. CONCLUSION: Hip arthroplasty utilization continues to increase among younger patients but has declined in older ones. Continued demographic pressure and recovery from COVID-19 disruptions are expected to drive further increases in procedure volume.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair of Health Economics, Policy and Management, School of Medicine, University of St. Gallen, Switzerland. Electronic address: jonas.backes@unisg.ch.
- OPZ Graz, Orthopedic and Physiotherapy Center Graz, Austria. Electronic address: pabinger@opz.at.
- Study Center, University of Music and Performing Arts Graz, Austria. Electronic address: harald@lothaller.net.
- Chair of Health Economics, Policy and Management, School of Medicine, University of St. Gallen, Switzerland. Electronic address: alexander.geissler@unisg.ch.
Zitieren
APA
Backes, J., Pabinger, C., Lothaller, H., & Geissler, A. (2025). Utilization rates of hip arthroplasty in OECD countries revised. Osteoarthritis and Cartilage, 33(12), 1475-1484. https://doi.org/10.1016/j.joca.2025.09.012
Vancouver
Backes J, Pabinger C, Lothaller H, Geissler A. Utilization rates of hip arthroplasty in OECD countries revised. Osteoarthritis and Cartilage. 2025;33(12):1475-1484. doi:10.1016/j.joca.2025.09.012
BibTeX
@article{Backes2025,
author = {Backes, Jonas and Pabinger, Christof and Lothaller, Harald and Geissler, Alexander},
title = {Utilization rates of hip arthroplasty in OECD countries revised},
journal = {Osteoarthritis and Cartilage},
year = {2025},
volume = {33},
number = {12},
pages = {1475--1484},
doi = {10.1016/j.joca.2025.09.012}
}
EUVIMED